Centers for Disease Control and Prevention
CDC request for public input on public health genomics
The Centers for Disease Control and Prevention (CDC) issued a Request for Information for comments, data, and other information helpful to assess the most important steps in research, policy, and practice for the field of public health genomics in the next five years.
Read PMC's comment here.
Evaluation of Genomic Applications in Practice and Prevention (EGAPP™)
In 2004, the Centers for Disease Control and Prevention launched the EGAPP™ initiative to establish and test a systematic, evidence-based process for evaluating genetic tests and other applications of genomic technology that are in transition from research to clinical and public health practice.
A key EGAPP™ goal is to provide objective, timely, and credible information that is clearly linked to available scientific evidence. This information will allow health care providers and payers, consumers, policymakers, and others to distinguish genetic tests that are safe and useful.
Read more about the EGAPP™ initiative in the decade report (10 Years of Public Health Genomics at CDC 1997 - 2007)
- Policy Update
- About PMC Public Policy
- Comparative Effectiveness
- Consumer Genomics
- Health Information Technology
- Incentives for Personalized Medicine
- Intellectual Property
- Learning Health Care System
- Privacy, Confidentiality and Patients' Rights
- Public and Private Reimbursement
- Regulatory Oversight
- Research Funding and Support